A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalomyopathies

Area of Science:

• Biochemistry
• Genetics
• Neuroscience

Background:

• Mitochondrial DNA (mtDNA) mutations, particularly in tRNA genes, are implicated in degenerative neuromuscular disorders.
• These mutations disrupt the oxidative phosphorylation (OXPHOS) system, crucial for cellular energy production.
• Specific point mutations, like A8344G in tRNA(Lys) (MERRF) and A3243G in tRNA(Leu) (MELAS), are well-documented.

Purpose of the Study:

• To develop and validate a sensitive method for detecting specific mtDNA point mutations associated with neuromuscular diseases.
• To enable simultaneous detection of multiple mtDNA alterations, including those in protein-coding genes.
• To establish a reliable assay for identifying heteroplasmic mutations, even when present at low percentages (<1%).

Main Methods:

• Utilizing allele-specific amplification of altered mitochondrial DNA.
• Developing a method capable of simultaneous detection of multiple mtDNA point mutations.
• Employing a sensitive assay to detect mutations present at low heteroplasmic levels.

Main Results:

• The developed assay reliably detects heteroplasmic point mutations in mtDNA.
• Simultaneous detection of mutations in tRNA genes (e.g., A8344G, A3243G) and protein-coding genes is feasible.
• The assay demonstrates high sensitivity, detecting mutations present at less than 1% of total mtDNA.

Conclusions:

• Allele-specific amplification provides a robust method for diagnosing mitochondrial disorders caused by mtDNA point mutations.
• This assay facilitates the detection of key mutations linked to MERRF and MELAS syndromes.
• The technique's sensitivity is crucial for identifying pathogenic mtDNA mutations, improving diagnostic capabilities for neuromuscular diseases.